FDA Inspection 1178524 — Biocon Biologics Limited
The FDA completed an inspection of Biocon Biologics Limited on Aug 26, 2022 in Bengaluru. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Aug 26, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)